Feng Tay Enterprises (9910) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
15 Jul, 2026Company overview
Founded in 1971 with headquarters in Yunlin Science and Industrial Park, Taiwan.
Specializes in shoe manufacturing and sales with a capital of NTD 9,875 million.
Production capacity is distributed across China (10%), Indonesia (14%), Vietnam (46%), and India (30%).
Employs approximately 135,000 people.
Financial performance (2025 2Q and 1-2Q)
2Q 2025 revenue was NT$20,400 million, down 2% QoQ and 8% YoY.
2Q 2025 net profit margin dropped to 4%, with EPS at NT$0.73, down 37% QoQ and 54% YoY.
1-2Q 2025 revenue totaled NT$41,123 million, a 4% YoY decrease; net income was NT$2,025 million, down 33% YoY.
Gross margin improved to 24% in 2Q 2025, up 3ppt YoY.
Annualized ROE for 2Q 2025 was 13%, down from 26% YoY.
Balance sheet and cash flow
Total assets as of June 30, 2025, were NT$49,266 million; equity was NT$22,638 million.
Cash balance decreased to NT$3,028 million from NT$5,141 million at year-end 2024.
Bank loans reduced to NT$3,916 million, and dividend payable increased to NT$5,040 million.
Cash from operating activities in 1-2Q 2025 was NT$2,441 million; capital expenditures were NT$1,553 million.
Inventory turnover days increased to 51 days as of June 2025.
Latest events from Feng Tay Enterprises
- Q1 2024 revenue and profit rose sharply, with improved margins and robust global operations.9910
Investor presentation15 Jul 2026 - 2Q 2024 saw robust revenue and profit growth, with EPS up 32% YoY and strong cash flow.9910
Investor presentation15 Jul 2026 - 3Q 2024 saw revenue up 2% QoQ, but EPS fell 15% YoY amid steady global operations.9910
Investor presentation15 Jul 2026 - Revenue and profit rose in 2024, with EPS up 18% and ROE reaching 23%.9910
Investor presentation15 Jul 2026 - Q1 2025 saw modest revenue growth but declining profit and negative operating cash flow.9910
Investor presentation15 Jul 2026 - Q3 2025 saw strong profit recovery and EPS growth, despite lower YTD revenue and net income.9910
Investor presentation15 Jul 2026 - Revenue and profit declined in 2025, but operational cash flow remained robust.9910
Investor presentation15 Jul 2026 - Q1 2026 revenue and net income declined sharply, with negative operating cash flow.9910
Investor presentation15 Jul 2026 - Q1 2024 saw strong revenue and profit growth, with improved margins and a major asset sale.9910
Q1 202415 Jul 2026